ZIC1 Overexpression Is Oncogenic in Liposarcoma

Liposarcomas are aggressive mesenchymal cancers with poor outcomes that exhibit remarkable histologic diversity, with five recognized subtypes. Currently, the mainstay of therapy for liposarcoma is surgical excision since liposarcomas are often resistant to traditional chemotherapy. In light of the...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Brill, Elliott, Gobble, Ryan, Angeles, Christina, Lagos-Quintana, Mariana, Crago, Aimee, Laxa, Bernadette, DeCarolis, Penelope, Zhang, Lei, Antonescu, Cristina, Socci, Nicholas D., Taylor, Barry S., Sander, Chris, Koff, Andrew, Singer, Samuel
Format: Artigo
Jezik:Inglês
Izdano: 2010
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3266950/
https://ncbi.nlm.nih.gov/pubmed/20713527
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-10-0745
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items